<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">299606</id>
  <title nil="true"/>
  <common-name>N-[(5e)-5-[(4-nitrophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pyridine-4-carboxamide</common-name>
  <description>N-[(5e)-5-[(4-nitrophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pyridine-4-carboxamide belongs to the pyridinecarboxylic acids and derivatives, a subclass of pyridines and derivatives within the organic compounds. It is an organoheterocyclic compound with the formula C16H10N4O4S2 and an average molecular weight of 386.40 g/mol.</description>
  <cas>68711-02-4</cas>
  <pubchem-id>6446937</pubchem-id>
  <chemical-formula>C16H10N4O4S2</chemical-formula>
  <weight>386.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-28T16:13:51Z</created-at>
  <updated-at type="dateTime">2026-08-28T16:13:51Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC(=CC=C1C=C2C(=O)N(C(=S)S2)NC(=O)C3=CC=NC=C3)[N+](=O)[O-]</moldb-smiles>
  <moldb-formula>C16H10N4O4S2</moldb-formula>
  <moldb-inchi>InChI=1S/C16H10N4O4S2/c21-14(11-5-7-17-8-6-11)18-19-15(22)13(26-16(19)25)9-10-1-3-12(4-2-10)20(23)24/h1-9H,(H,18,21)/b13-9+</moldb-inchi>
  <moldb-inchikey>SOMHQKDZPNHHCS-UKTHLTGXSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">386.0143472</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM295499</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[(5e)-5-[(4-nitrophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pyridine-4-carboxamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridines and derivatives</klass>
  <subklass>Pyridinecarboxylic acids and derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0250908</sync-id>
  <structure-inchikey>SOMHQKDZPNHHCS-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000000000040000000000000000000000000000100000000000000404000000021000000000000002100000000000000000000000002004000000200000000000000000000000000000020000010000200001000000000400040000000010000000200000100010000004400000100000000000000000000011000000000000000000000000000000080000000001000800002000000000020000000000000000000000000084000000000000000000000000000000000000000000000000000001000000000000000400400000000040000000200000400000000420000000000002040000000800400000000001000000000000000004008</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle>ï¾­Þ������������������������€��@h�������@h�������@(������@h�������@h�������@(�������h��������(�������(�������(�������(�������(�������(������� ������h��������(�������(������@(������@h�������@h�������@(������@h�������@h������� *��������(������ *���ÿ�����h���h���h���h���h��� ��(��� �	(��
 
� ��(���
���� ��(��� ��h���h���h���h���h��� ��(��� ��h�����h�B���������������
�����������������</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:09:55Z</structure-indexed-at>
</compound>
